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Many receptors coupled to the pertussis toxin-sensitive Gi/o proteins stimulate the mitogen-
activated protein kinase (MAPK) pathway. The role of the a chains of these G proteins in MAPK
activation is poorly understood. We investigated the ability of Gao to regulate MAPK activity by
transient expression of the activated mutant Gao-Q205L in Chinese hamster ovary cells. Gao-
Q205L was not sufficient to activate MAPK but greatly enhanced the response to the epidermal
growth factor (EGF) receptor. This effect was not associated with changes in the state of tyrosine
phosphorylation of the EGF receptor. Gao-Q205L also potentiated MAPK stimulation by activated
Ras. In Chinese hamster ovary cells, EGF receptors activate B-Raf but not Raf-1 or A-Raf. We
found that expression of activated Gao stimulated B-Raf activity independently of the activation
of the EGF receptor or Ras. Inactivation of protein kinase C and inhibition of phosphatidylinosi-
tol-3 kinase abolished both B-Raf activation and EGF receptor-dependent MAPK stimulation by
Gao. Moreover, Gao-Q205L failed to affect MAPK activation by fibroblast growth factor receptors,
which stimulate Raf-1 and A-Raf but not B-Raf activity. These results suggest that Gao can
regulate the MAPK pathway by activating B-Raf through a mechanism that requires a concomi-
tant signal from tyrosine kinase receptors or Ras to efficiently stimulate MAPK activity. Further
experiments showed that receptor-mediated activation of Gao caused a B-Raf response similar to
that observed after expression of the mutant subunit. The finding that Gao induces Ras-indepen-
dent and protein kinase C- and phosphatidylinositol-3 kinase-dependent activation of B-Raf and
conditionally stimulates MAPK activity provides direct evidence for intracellular signals connect-
ing this G protein subunit to the MAPK pathway.
INTRODUCTION
The mitogen-activated protein kinase (MAPK) pathway
plays a central role in the stimulation of cell growth by cell
surface receptors (Marshall, 1994; Cobb and Goldsmith,
1995). Both tyrosine kinase receptors and G protein-coupled
receptors lead to the activation of the serine/threonine ki-
nases known as p44 MAPK and p42 MAPK or extracellular
signal-regulated kinases 1 and 2, which phosphorylate and
regulate a large array of substrates, including nuclear tran-
scription factors that control genes essential for cell prolif-
eration (Davis, 1993). A well-characterized signaling path-
way links tyrosine kinase receptors to MAPK activation.
Growth factor-induced tyrosine phosphorylation of these
receptors, and the subsequent recruitment of the adaptor
molecules Shc and Grb2 bring to the plasma membrane the
Sos protein, which acts as a guanine nucleotide exchange
factor for Ras (Boguski and McCormick, 1993; Schlessinger,
1994). Ras activation is followed by a kinase cascade in
which one or more of the proteins referred as Raf-1, A-Raf,
and B-Raf phosphorylate and activate the MAPK/extracel-
lular signal-regulated kinase kinases (MEK), which in turn
phosphorylate and activate p44 and p42 MAPK (Marshall,
1994; Cobb and Goldsmith, 1995; Marais and Marshall, 1996;
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Campbell et al., 1998). G protein-coupled receptors appear to
initiate a variety of pathways that mediate Ras-dependent or
Ras-independent stimulation of the MAPK cascade (van
Biesen et al., 1996b; Gutkind, 1998; Luttrell et al., 1999). These
pathways, which involve various G protein subunits and
downstream signaling molecules, have been only partially
elucidated.
A large group of G protein-coupled receptors induce mi-
togenic responses by activating members of the pertussis
toxin (PTX)-sensitive family of G proteins (Pouyssegur and
Seuwen, 1992; van Biesen et al., 1996b). This family includes
four G proteins potentially involved in mitogenic signaling
pathways: Gi1, Gi2, Gi3, and Go (Neer, 1995). Microinjection
of inhibitory antibodies has shown that both Gi2 and Go
heterotrimers can exert a positive effect on cell proliferation
(LaMorte et al., 1992; Baffy et al., 1994). Evidence for a mito-
genic action of the a chains of these G proteins comes from
studies using constitutively activated mutants. Transfection
of activated Gai2 causes transformation of Rat-1 fibroblasts
and enhances the proliferation of other cell lines (Hermouet
et al., 1991; Pace et al., 1991; Gupta et al., 1992). Expression of
activated Gao can induce transformation of NIH 3T3 cells
(Kroll et al., 1992). Furthermore, mutations that activate Gai2
have been identified in a limited subset of human tumors
(Lyons et al., 1990). The ability of Gi/o-coupled receptors to
activate the MAPK pathway is well documented. A variety
of these receptors have been shown to stimulate MAPK
activity in fibroblasts and other cell types (van Biesen et al.,
1996b; Gutkind, 1998). Several lines of evidence indicate that
the Gbg complex plays an important role in PTX-sensitive
MAPK activation (van Biesen et al., 1996b; Gutkind, 1998).
Cells expressing free Gbg heterodimers have revealed that
these subunits initiate a phosphatidylinositol-3 kinase
(PI3K)- and Src-dependent pathway that leads to tyrosine
phosphorylation of Shc, formation of a Shc–Grb2 complex,
and Ras-dependent activation of the MAPK cascade (van
Biesen et al., 1996b; Gutkind, 1998). Although both Gi2 and
Go appear to be involved in the MAPK responses induced
by receptors coupled to PTX-sensitive G proteins (Pace et al.,
1995; van Biesen et al., 1996a), a role of Gai2 and Gao in
regulation of the MAPK pathway has not been clearly es-
tablished. In fact, prolonged expression of activated Gai2 is
accompanied by increased MAPK activity in Rat-1 fibro-
blasts, but stable or transient transfection of the same sub-
unit in other cell types does not induce MAPK activation
(Gallego et al., 1992; van Biesen et al., 1996b; Gutkind, 1998).
It has been proposed that in Chinese hamster ovary (CHO)
cells the muscarinic M1 receptor, which couples to both Gq
and Go, activates a Gao-dependent pathway leading to
MAPK stimulation (van Biesen et al., 1996a). However, direct
evidence for regulation of the MAPK pathway by this Ga
subunit has not been provided yet.
Here we report that expression of the constitutively acti-
vated mutant Gao-Q205L (Kroll et al., 1992; Wong et al., 1992)
in CHO cells is not sufficient to induce MAPK activation but
strongly potentiates the stimulatory effects of the epidermal
growth factor (EGF) receptor and Ras. We show that Gao
can regulate the activity of the B-Raf kinase through a Ras-
independent and protein kinase C (PKC)- and PI3K-depen-
dent mechanism. Our results suggest that B-Raf regulation
mediates, at least in part, the action of Gao on the MAPK
pathway.
MATERIALS AND METHODS
Materials
The Gao antiserum was generated by immunization of rabbits with
a synthetic peptide corresponding to the C-terminal sequence
ANNLRGCGLY (Baffy et al., 1994). Mouse monoclonal antibodies
against phosphotyrosine and human EGF receptor (LA1) were from
Upstate Biotechnology (Lake Placid, NY); the anti-hemagglutinin
(HA) mouse monoclonal antibody 12CA5 was from Boehringer
Mannheim (Mannheim, Germany); the anti-phospho-Akt (Ser-473)
mouse monoclonal antibody 4E2 was from New England BioLabs
(Beverly, MA); and rabbit polyclonal antibodies against p42 MAPK
(C-14), Raf-1 (C-20), A-Raf (C-20), B-Raf (C-19), and human EGF
receptor (1005) were from Santa Cruz Biotechnology (Santa Cruz,
CA). ATP, myelin basic protein (MBP), phorbol 12-myristate 13-
acetate (PMA), LY 294002, and dopamine were purchased from
Sigma (St. Louis, MO). Human EGF was from Boehringer Mann-
heim; wortmannin, GF 109203X, and human fibroblast growth fac-
tor (FGF) were from Calbiochem (La Jolla, CA), and PTX was from
List Biological Laboratories (Campbell, CA). Recombinant glutathi-
one S-transferase (GST)-p42 MAPK and GST-MEK1 were from Up-
state Biotechnology; protein A-Sepharose CL-4B and GammaBind
G-Sepharose were from Amersham Pharmacia Biotech (Uppsala,
Sweden); and [g-32P]ATP was from DuPont New England Nuclear
(Boston, MA). All other chemicals were reagent grade.
DNA Constructs
The cDNAs encoding wild-type Ga, Gb, and Gg subunits, consti-
tutively activated Ga chains (Gao-Q205L, Gai2-Q205L, Gai3-Q204L,
and Gaq-R183C) (Conklin et al., 1992; Wong et al., 1992), and the
human dopaminergic D2L receptor (Wong et al., 1992) were in the
pcDNAI expression vector. L. Beguinot (Scientific Institute San Raf-
faele, Milan, Italy) provided the pCO11 plasmid containing humam
EGF receptor cDNA. HA-p44 MAPK (Meloche et al., 1992a) in
pcDNAI and pRSV vectors containing cDNAs for the activated
mutant Ras-Q61L and the dominant negative mutant N17-Ras were
gifts from E.P. Sturani and R. Zippel (University of Milan, Milan,
Italy).
Cell Culture, DNA Transfection, and Preparation of
Lysates
CHO cells were maintained in culture in Dulbecco’s modified Ea-
gle’s medium-Ham’s F-12 (1:1) supplemented with 10% FCS. Tran-
sient transfections were performed using the Transfectam reagent
(Promega, Madison, WI). Cells were grown to 60–70% confluence in
6- or 10-cm dishes, washed with serum-free medium, and incubated
in the same medium (1.5 ml per 6-cm dish and 4 ml per 10-cm dish)
containing DNA:Transfectam (1 mg:2 ml) complexes. In all experi-
ments, the total amount of transfected DNA was kept constant by
addition of empty vector. After 5 h at 37°C, dishes were washed and
incubated in 10% FCS medium for 24 h. Transfection efficiencies
were determined by transfection of a plasmid encoding a mutant
green fluorescent protein (pEGFP-N1; Clontech, Cambridge, United
Kingdom). Expression was detected by fluorescence microscopy
and was consistently observed in ;35% of the transfected cells. For
the various assays, cells were serum starved for 18 h in medium
containing 0.5% FCS and, where indicated, pretreated with the
appropriate agents and/or incubated in serum-free medium in the
absence or presence of EGF or dopamine. The cells were then
washed once with ice-cold Ca21- and Mg21-free PBS and incubated
on ice for 20 min with the lysis buffer specified for each assay (0.6 ml
per 6-cm dish and 1 ml per 10-cm dish). Cell lysates were cleared by
centrifugation at 13,000 rpm for 15 min at 4°C.
Measurement of MAPK Activity
The activities of endogenous p42 MAPK and HA-p44 MAPK were
determined by an immune complex kinase assay. Cells in 6-cm
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dishes were lysed in buffer containing 50 mM Tris-HCl, pH 7.5, 100
mM NaCl, 5 mM EDTA, 40 mM Na4P2O7, 200 mM Na3VO4, 1%
Triton X-100, 1 mM dithiothreitol, 1 mM PMSF, and 10 mg/ml
chymostatin, leupeptin, antipain, and pepstatin (CLAP). Lysates
were incubated at 4°C with 1 mg of anti-p42 MAPK antibodies for
1 h or with 3 mg of anti-HA antibodies for 2 h. Immune complexes
were collected by incubation with 50 ml of protein A-Sepharose
(50% slurry) for 1 h at 4°C, centrifuged (2 min at 3000 rpm at 4°C),
and washed three times in lysis buffer and twice in kinase buffer (40
mM HEPES-NaOH, pH 7.5, 10 mM MgCl2, 1 mM EGTA, 200 mM
Na3VO4, 2 mM dithiothreitol, 1 mM PMSF, 10 mg/ml CLAP, and 3
mM benzamidine). The final pellets were resuspendend in 50 ml of
kinase buffer supplemented with 250 mg/ml MBP as a substrate.
The kinase reaction was started by addition of 5 ml of 500 mM ATP
containing 4 mCi of [g-32P]ATP, incubated at 30°C for 30 min, and
stopped with 5 ml of 88% formic acid. After a brief centrifugation, 35
ml of the supernatant fraction were spotted on squares of Whatman
(Maidstone, United Kingdom) P81 paper. Free [g-32P]ATP was
eluted by four washes in 150 mM phosphoric acid, and the amount
of radioactivity incorporated into MBP was measured by scintilla-
tion counting. Blank kinase reactions, carried out after incubation of
antibodies with lysis buffer and protein A-Sepharose, were always
performed. The radioactivity of these reactions (;500 cpm) was
subtracted from the result of each sample.
Measurement of Raf Activity
The ability of Raf-1, A-Raf, and B-Raf to activate MEK was mea-
sured by an immune complex “coupled” assay in which recombi-
nant GST-MEK1 activates recombinant GST-p42 MAPK (Alessi et
al., 1995). Cells in 6- or 10-cm dishes were lysed in buffer containing
20 mM Tris-HCl, pH 7.5, 5 mM MgCl2, 10 mM EGTA, 50 mM NaF,
40 mM Na4P2O7, 200 mM Na3VO4, 1% Triton X-100, 20 mM N-octyl-
b-d-glucopyranoside, 1 mM PMSF, 10 mg/ml CLAP, and 20 mg/ml
aprotinin. Lysates were incubated with antibodies against Raf-1,
A-Raf, or B-Raf (1.5 mg/ml) for 2 h at 4°C. Immune complexes were
collected with protein A-Sepharose (50 ml of 50% slurry) for 1 h at
4°C, centrifuged, and washed three times in lysis buffer without
PMSF and twice in washing buffer (50 mM Tris-HCl, pH 7.5, 0.1 mM
EGTA, 0.5 mM Na3VO4, and 0.1% 2-mercaptoethanol). For the first
step of the kinase reaction, pellets were resuspended in 30 ml of
kinase buffer (30 mM Tris-HCl, pH 7.5, 10 mM magnesium acetate,
0.1 mM EGTA, 0.1% 2-mercaptoethanol, 0.03% Brij 35, 20 mM
N-octyl-b-d-glucopyranoside, and 200 mM ATP) supplemented
with 3 mg/ml GST-MEK1 and 30 mg/ml GST-p42 MAPK. After 30
min at 30°C, 15 ml of the supernatant were mixed with 15 ml of
washing buffer containing 1 mg/ml BSA. Activation of GST-p42
MAPK was assayed by incubating 10 ml of this mixture with 40 ml
of kinase buffer (50 mM Tris-HCl, pH 7.4, 12.5 mM magnesium
acetate, 0.1 mM EGTA, 50 mM ATP, and 2 mCi [g-32P]ATP) supple-
mented with 400 mg/ml MBP. The reaction (15 min at 30°C) was
terminated by spotting 40 ml on squares of Whatman P81 paper, and
radioactivity incorporated into MBP was determined as described
for p42 MAPK and HA-p44 MAPK assays. The values of blank
reactions performed after incubation of antibodies with lysis buffer
and protein A-Sepharose (;4000 cpm) were subtracted from the
result of each sample. Preliminary experiments showed that no
activity was associated with protein A-Sepharose incubated with
lysates in the absence of antibodies. The activity detected in reac-
tions performed without GST-MEK1 was ;15% (for Raf-1 and A-
Raf) and ,0.01% (for B-Raf) of that observed in the presence of the
recombinant kinase. The presence of comparable amounts of Raf in
the immunoprecipitates used in the kinase assay was verified by
immunoblot analysis of the protein A-Sepharose pellets as de-
scribed below.
Analysis of Protein Expression and Tyrosine
Phosphorylation
Expression and tyrosine phosphorylation of transfected EGF recep-
tors were evaluated by immunoprecipitation and subsequent im-
munoblotting. Cells in 10-cm dishes were lysed in buffer containing
20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM EDTA, 40 mM
Na4P2O7, 1 mM Na3VO4, 1% Triton X-100, 10% glycerol, 1 mM
PMSF, and 10 mg/ml CLAP. Lysates were precleared with protein
G-Sepharose (40 ml of 50% slurry) for 45 min at 4°C and incubated
with 5 mg of anti-EGF receptor LA1 antibody overnight at 4°C.
Immune complexes were collected with protein G-Sepharose (60 ml
of 50% slurry) for 2 h at 4°C, centrifuged, and washed three times in
lysis buffer. Two equal parts of each immunoprecipitate were sep-
arated by 7.5% SDS-PAGE and transferred to nitrocellulose filters
(Schleicher & Schuell, Keene, NH). For detection of the EGF recep-
tor, filters were blocked for 1 h in Blotto (50 mM Tris-HCl, pH 7.4,
150 mM NaCl, 0.05% Tween 20, 0.01% sodium azide, and 5% nonfat
dry milk), incubated overnight at 4°C in Blotto containing 0.4 mg/ml
anti-EGF receptor 1005 antibody, incubated for 2 h in Blotto with
horseradish peroxidase-conjugated secondary antibodies (Bio-Rad,
Hercules, CA), and finally processed for enhanced chemilumines-
cence (Amersham Pharmacia Biotech). For analysis of tyrosine
phosphorylation, filters were kept for 2 h in BSA blocking solution
(50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.02% sodium azide, and
5% BSA) and incubated in the same solution with anti-phosphoty-
rosine antibodies (1 mg/ml) overnight at 4°C. Detection was per-
formed with 125I-labeled secondary antibodies (Amersham Pharma-
cia Biotech). Preliminary experiments showed that both the LA1 and
1005 antibodies used in these studies recognize equally well the
nonphosphorylated and phosphorylated forms of the EGF receptor.
For detection of Akt phosphorylation, cells were lysed in buffer
containing 20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM EDTA, 20
mM NaF, 40 mM Na4P2O7, 1 mM Na3VO4, 1% Triton X-100, 10%
glycerol, 1 mM PMSF, 10 mg/ml CLAP, and 20 mg/ml aprotinin.
Lysates (150 mg of protein) were separated by 7.5% SDS-PAGE and
immunoblotted using anti-phospho-Akt antibodies. The expression
of transfected Gao and HA-p44 MAPK was assessed by immuno-
blotting of cell lysates (100 mg of protein) prepared as described for
MAPK assays and separated by 10% SDS PAGE. Immunoblot anal-
ysis of Raf proteins was performed on immunoprecipitates pre-
pared as described for kinase assays and resolved by 7.5% SDS-
PAGE. Filters were incubated with Gao antiserum (1:200), anti-HA
antibody (2.5 mg/ml), anti-phospho-Akt antibody (0.5 mg/ml), or
anti-Raf-1, A-Raf, and B-Raf antibodies (0.3 mg/ml) overnight at 4°C
in Blotto. The Gao antiserum was detected with 125I-labeled protein
A (Amersham Pharmacia Biotech), and all other antibodies were
detected with horseradish peroxidase-conjugated secondary anti-
bodies and enhanced chemiluminescence.
RESULTS
Activated Gao Potentiates EGF Receptor-dependent
MAPK Stimulation
Transient expression of wild-type or mutationally activated
Gao in CHO cells did not lead to a significant activation of
endogenous p42 MAPK (Figure 1A) or cotransfected HA-
p44 MAPK (Figure 1B). Previous studies have detected stim-
ulation of the MAPK pathway by certain PTX-insensitive Ga
chains only in the presence of growth factors acting through
tyrosine kinase receptors (De Vivo and Iyengar, 1994;
Voyno-Yasenetskaya et al., 1994). The responses induced by
various receptors coupled to Gi/o proteins suggest that spe-
cific subunits of these heterotrimers can also mediate signals
that potentiate tyrosine kinase receptor-dependent MAPK
activation (Meloche et al., 1992b; Vouret-Craviari et al., 1993;
Fujitani and Bertrand, 1997). We therefore investigated the
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Figure 1. Effect of activated Gao on MAPK activity. CHO cells transfected in 6-cm dishes were placed for 18 h in 0.5% FCS medium and
incubated for 5 min in the absence or presence of 100 ng/ml EGF. MAPK activity was determined as described in MATERIALS AND
METHODS. (A) Endogenous p42 MAPK activity in cells transfected with 1.8 mg of Gao-wild-type (WT) or Gao-Q205L and, where indicated,
1.8 mg of EGF receptor (EGFR). The data represent means 6 SE of two to four independent experiments performed in triplicate. (B) HA-p44
MAPK activity in cells transfected with 1.4 mg of HA-p44 MAPK, 1.4 mg of Gao-WT or Gao-Q205L and, where indicated, 1.4 mg of EGFR.
The data are means 6 SE of two independent experiments performed in duplicate. (C) Endogenous p42 MAPK activity in cells transfected
with 1.8 mg of wild-type (WT) or activated (QL and RC) Gai2, Gai3, and Gaq subunits, 1.4 mg of Gb1 and Gg2 chains, and, where indicated,
1.8 mg of EGFR. Means 6 SE from two independent experiments performed in duplicate are given. When nontransfected CHO cells were
incubated with 100 ng/ml EGF for 5 min, the values of endogenous p42 MAPK activity in the absence and presence of the growth factor were
4097 6 429 and 4278 6 620 cpm, respectively (n 5 4). Immunoblots show the expression of wild-type or activated Gao (A) and HA-p44 MAPK
(B) in cells transfected with different cDNAs. Similar results were obtained in two additional experiments.
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Figure 2. MAPK stimulation by activated Gao involves PKC and PI3K. (A–C and E) CHO cells in 6-cm dishes were transfected with 1.8 mg
of EGFR and 1.8 mg of either empty vector or Gao-Q205L and assayed for endogenous p42 MAPK activity as described in the legend to Figure
1. (A) Effect of PMA pretreatment on MAPK activity. Cells were incubated for 18 h in 0.5% FCS medium containing 1 mM PMA before
stimulation with 100 ng/ml EGF or 1 mM PMA for 5 min. The data represent means 6 SE of two independent experiments performed in
duplicate. (B, C, and E) Effects of PKC or PI3K inhibitors on MAPK activity. Cells were serum starved for 18 h and incubated for 15 min with
1 mM GF 109203X (B), the indicated concentrations of wortmannin (C), or 20 mM LY 294002 (E) before stimulation with 100 ng/ml EGF for
5 min. The data are means 6 SE of four to nine observations. Additional assays showed that GF 109203X completely abolished the increase
in p42 MAPK activity induced by short exposure to PMA. (D) Effect of wortmannin on Akt phosphorylation. Nontransfected CHO cells
grown in 6-cm dishes were serum starved for 18 h, incubated with the indicated concentrations of wortmannin for 15 min, and stimulated
with 20 ng/ml PDGF for 10 min. Phosphorylated Akt was detected by immunoblot analysis of cell lysates with specific antibodies as
described in MATERIALS AND METHODS. The molecular mass (kilodaltons) of a marker protein is shown to the left, and the position of
phosphorylated Akt is indicated by an arrow. Data are representative of two similar experiments.
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ability of Gao to stimulate endogenous p42 MAPK in CHO
cells transiently expressing the EGF receptor. In nontrans-
fected CHO cells, EGF had no significant effect on p42
MAPK activity (see legend to Figure 1). In the presence of
EGF receptors, basal p42 MAPK activity was not signifi-
cantly different from that detected in control cells and in-
creased ;15-fold upon stimulation with 100 ng/ml EGF for
5 min (Figure 1A). Coexpression of Gao-Q205L induced a
modest elevation of unstimulated p42 MAPK activity and a
twofold enhancement of the response induced by EGF. In
contrast, no significant changes in the p42 MAPK response
to the EGF receptor were observed in cells coexpressing
wild-type Gao. These results could not be accounted for by
variable levels of expression of the Gao subunit (Figure 1A)
or the EGF receptor (see Figure 3) in cells transfected with
different cDNA combinations. When coexpressed with the
EGF receptor, activated Gao significantly increased un-
stimulated activity and greatly amplified the effect of EGF
also in HA-p44 MAPK assays (Figure 1B). These responses
were not accompanied by detectable variations of HA-p44
MAPK expression. As shown in Figure 1C, measurements of
p42 MAPK activity revealed that the stimulatory effect of
Gao-Q205L on the MAPK pathway was not mimicked by
mutationally activated Gai2, Gai3, or Gaq subunits. Expres-
sion of Gb1g2 chains induced per se a fourfold activation of
p42 MAPK, as expected from previous results obtained in
CHO cells and other systems (Hawes et al., 1995; van Biesen
et al., 1996b; Gutkind, 1998), but failed to potentiate the
response to the EGF receptor (Figure 1C). Similar results
were obtained when the effects of activated Gai2, Gai3, and
Gaq subunits and Gb1g2 complexes were tested in HA-p44
MAPK assays (our unpublished results).
Regulation of the MAPK Pathway by Gao Involves
PKC and PI3K
It has been reported that MAPK activation by some recep-
tors capable of coupling to the Go protein is dependent on
PKC activity (van Biesen et al., 1996a; Wylie et al., 1999). We
therefore investigated the role of PKC in the regulation of
the MAPK pathway mediated by Gao. Cells transfected with
the EGF receptor in the absence or presence of Gao-Q205L
were incubated with PMA for 18 h to down-regulate the
expression of phorbol ester-sensitive PKC isozymes. As
shown in Figure 2A, this procedure abolished the stimula-
tion of p42 MAPK activity induced by short exposure to
PMA. PKC down-regulation did not affect the p42 MAPK
response to EGF in cells transfected with the EGF receptor
but completely inhibited the enhancement of the stimulatory
effect of the growth factor observed after coexpression of
Gao-Q205L. Pretreatment with PMA also prevented the in-
crease in unstimulated p42 MAPK activity observed in cells
expressing activated Gao. Entirely comparable results were
obtained using the PKC inhibitor GF 109203X (Toullec et al.,
1991) (Figure 2B).
Activation of PI3K has been identified as a major signaling
pathway leading to MAPK stimulation (Toker and Cantley,
1997). Upon activation of Gi/o-coupled receptors, PI3K is
believed to mediate stimulation of MAPK activity by the G
protein bg subunits (van Biesen et al., 1996b; Gutkind, 1998).
To determine whether the action of Gao on MAPK also
involves any of the PI3K isoforms, we used the inhibitors
wortmannin (Ui et al., 1995) and LY 294002 (Vlahos et al.,
1994). As shown in Figure 2C and previously described in
other systems (Wennstrom and Downward, 1999), no signif-
icant effect of 100 nM wortmannin was detected in cells
transfected with the EGF receptor. In contrast, a concentra-
tion of wortmannin as low as 5 nM efficiently reduced the
high p42 MAPK activity displayed by cells coexpressing
Gao-Q205L. Complete inhibition was achieved in the pres-
ence of 25 nM wortmannin. We compared this effect with the
inhibition of Akt phosphorylation, a well-established PI3K-
dependent event (Toker and Cantley, 1997). In our experi-
ments, endogenous platelet-derived growth factor (PDGF)
receptors, but not transfected EGF receptors or endogenous
FGF receptors (our unpublished results), induced a detect-
able phosphorylation of Akt. As shown in Figure 2D, the
concentrations of wortmannin that inhibited Gao-mediated
p42 MAPK activation also blocked Akt phosphorylation by
PDGF. As shown in Figure 2E, LY 294002 mimicked the
effect of wortmannin on p42 MAPK activity. Taken together,
these results indicate that the Gao subunit potentiates
MAPK activation by the EGF receptor through a pathway
that involves both PKC and PI3K.
Gao Potentiates Ras Activation of the
MAPK Pathway
The effect of Gao on MAPK activity implies that this subunit
is able to modulate the function of at least one component of
the signaling pathway connecting the EGF receptor to
MAPK. We first checked whether, under the conditions used
in MAPK assays, Gao affects the state of tyrosine phosphor-
ylation of the EGF receptor itself. As shown in Figure 3,
immunoprecipitation of lysates from transfected cells with
anti-EGF receptor antibodies followed by immunoblot anal-
Figure 3. Effect of activated Gao on EGF receptor tyrosine phos-
phorylation. CHO cells in 10-cm dishes were transfected with 5 mg
of EGFR and 5 mg of empty vector, Gao-WT, or Gao-Q205L, serum
starved for 18 h, and stimulated with 100 ng/ml EGF for 5 min.
Immunoprecipitation (IP) with anti-EGFR antibodies and immuno-
blot analysis of the immunoprecipitates with anti-phosphotyrosine
or anti-EGFR antibodies were performed as described in MATERI-
ALS AND METHODS. The molecular masses (kilodaltons) of
marker proteins are shown to the left, and the position of the EGFR
is indicated by arrows. Data are representative of three similar
experiments.
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ysis with anti-phoshotyrosine antibodies failed to reveal a
significant effect of Gao-Q205L on basal or EGF-induced
tyrosine phosphorylation of the EGF receptor. To identify
possible sites of action of Gao downstream of the EGF re-
ceptor, we asked whether Gao-Q205L can potentiate the
stimulation of the MAPK pathway induced by constitutively
activated Ras. In control cells, expression of activated Ras
increased the activity of endogenous p42 MAPK (Figure 4A)
and cotransfected HA-p44 MAPK (Figure 4B) ;8- and 200-
fold, respectively. The responses of both forms of MAPK to
Ras were markedly enhanced by coexpression of Gao-
Q205L. These results indicate that Gao potentiates EGF re-
ceptor-dependent activation of the MAPK pathway at the
level or downstream of Ras.
Gao Activates B-Raf by a Ras-independent and
PKC- and PI3K-dependent Mechanism
The components of the MAPK cascade located immediately
downstream of Ras are the Raf kinases, Raf-1, A-Raf, and
B-Raf. The central role of Ras in activation of these kinases is
well established (Marais and Marshall, 1996; Campbell et al.,
1998). However, increasing evidence indicates that addi-
tional signals converge on the Raf proteins and, at least in
some cases, cooperate with Ras in regulating their function
(Marais and Marshall, 1996; van Biesen et al., 1996b; Marais
et al., 1997; Vossler et al., 1997; Campbell et al., 1998; York et
al., 1998). We therefore asked whether Gao can affect EGF
receptor-dependent activation of the Raf kinases. As shown
in Figure 5A, CHO cells were found to express Raf-1, A-Raf,
and two B-Raf isoforms migrating with approximate molec-
ular masses of 92 and 66 kDa. We first determined which of
these kinases are activated after stimulation of EGF recep-
tors. The activity of each type of Raf was measured by a
coupled assay in which the kinase immunoprecipitated from
cell lysates is used to activate sequentially recombinant
forms of MEK and MAPK. As shown in Figure 5B, CHO
cells transfected with the EGF receptor displayed no activa-
tion of Raf-1 and A-Raf but an ;40% increase in B-Raf
activity upon exposure to EGF. It should be noted that in
these assays the basal activity of B-Raf was much higher
than those of Raf-1 and A-Raf. This finding most probably
reflects not only different levels of expression of the various
Raf proteins in CHO cells but also the elevated rate of basal
activity of B-Raf, which has been demonstrated by previous
work (Marais et al., 1997). However, the lack of effect of EGF
on Raf-1 and A-Raf could not be explained by a failure to
detect increases in the relatively low activities of these ki-
nases, because our assays easily revealed stimulation of
Raf-1 by transfected dopaminergic D2 receptors (our unpub-
lished results) and stimulation of both Raf-1 and A-Raf by
endogenous FGF receptors (Figure 6A). We next examined
the responses of the various Raf kinases to Gao. The exper-
iments presented in Figure 5C showed that activated but not
wild-type Gao was able to stimulate B-Raf activity. Parallel
measurements of the activities of Raf-1 and A-Raf re-
vealed no significant effect of Gao-Q205L on these kinases
(our unpublished results). In sharp contrast with the re-
sults obtained in MAPK assays, B-Raf activation by Gao
was completely independent of the EGF receptor. Gao-
Q205L caused an ;50% increase in basal B-Raf activity
both in the absence and in the presence of EGF receptors
and enhanced the stimulation induced by EGF in a simply
additive manner.
As shown in Figure 5D, the activation of B-Raf induced
by Gao-Q205L was not inhibited when endogenous Ras
function was blocked by coexpression of the dominant
negative mutant N17-Ras. In contrast, prolonged PMA
pretreatment and exposure to GF 109203X, wortmannin,
and LY 294002, which prevent the ability of Gao-Q205L to
potentiate EGF receptor-dependent MAPK stimulation,
also abolished the effect of the mutant subunit on B-Raf
(Figure 5D). Taken altogether, our findings indicate that
Figure 4. Effect of activated Gao on Ras-stimulated MAPK activity.
CHO cells transfected in 6-cm dishes were serum starved for 18 h
and assayed for MAPK activity as described in the legend to Figure
1. (A) Endogenous p42 MAPK activity in cells transfected with
Gao-WT or Gao-Q205L (1.8 mg) and either empty vector or Ras-
Q61L (2.2 mg). (B) HA-p44 MAPK activity in cells transfected with
HA-p44 MAPK (1.4 mg), Gao-WT or Gao-Q205L (1.4 mg), and either
empty vector or Ras-Q61L (1.4 mg). Data represent means 6 SE of
two separate experiments performed in duplicate. Expression of
Ras-Q61L in the absence of exogenous Gao gave results similar to
those obtained in cells transfected with the wild-type subunit.
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Figure 5. Activated Gao stimulates B-Raf activity. (A) Expression of Raf proteins in CHO cells. Raf-1, A-Raf, and B-Raf were immunopre-
cipitated from lysates of nontransfected cells and detected by immunoblotting with specific antibodies as described in MATERIALS AND
METHODS. The molecular masses (kilodaltons) of marker proteins are shown to the left, and the positions of Raf-1, A-Raf, and B-Raf
migration are indicated by arrows. (B–D) CHO cells transfected in 10-cm dishes were serum starved for 18 h and assayed for endogenous
Raf-1, A-Raf, and B-Raf activities as described in MATERIALS AND METHODS. (B) Effect of EGFR stimulation on Raf activity. Cells were
transfected with 5 mg of EGFR and incubated for 5 min in the absence or presence of 100 ng/ml EGF. Data represent means 6 SE of two to
three independent experiments performed in triplicate. *, Significantly higher than basal (p , 0.01 by unpaired t test). In similar experiments
carried out with nontransfected CHO cells, basal B-Raf activity (106,370 6 7071 cpm) was not significantly increased by EGF (102,468 6 5748
cpm) (n 5 4). (C) Effect of activated Gao on B-Raf activity. Cells transfected with 5 mg of empty vector, Gao-WT or Gao-Q205L and, where
indicated, 5 mg of EGFR were incubated for 5 min in the absence or presence of 100 ng/ml EGF. Values are means 6 SE of three independent
experiments performed in triplicate. EGF induced a significant increase in B-Raf activity in all transfected cells (p , 0.01 by unpaired t test).
*, Significantly higher than values from cells transfected with vector or Gao-WT (p , 0.01 by unpaired t test). (D) Effects of N17-Ras
expression, PMA pretreatment, and PKC or PI3K inhibitors on Gao-mediated B-Raf activation. Cells were transfected with 4 mg of empty
vector or Gao-Q205L, and, where indicated, 8 mg of N17-Ras. PMA (1 mM), wortmannin (25 nM), GF 109203X (1 mM), and LY 294002 (20 mM)
were used as described in the legend to Figure 2. Results are expressed as percentages of inhibition of the increase induced by Gao-Q205L
and represent the mean 6 SE of two experiments in duplicate determinations. Expression of N17-Ras, PMA pretreatment, and the various
inhibitors did not modify B-Raf activity in cells transfected with vector. Additional assays showed that both PMA pretreatment and GF
109203X completely abolished the increase in B-Raf activity induced by 5-min stimulation with 1 mM PMA (;50%).
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Gao regulates the activity of B-Raf by a Ras-independent
and PKC- and PI3K-dependent mechanism that enables
the kinase to activate MEK and MAPK in in vitro assays
but not in intact cells. The simplest hypothesis suggested
by the data is that Gao-activated B-Raf can efficiently
couple to the downstream MAPK cascade when concom-
itantly reached by a regulatory signal provided by the
EGF receptor or Ras. This model predicts that activated
Gao should fail to potentiate the stimulation of MAPK
induced by B-Raf-independent pathways. We therefore
tested the effect of Gao-Q205L on the MAPK response to
endogenous FGF receptors, which stimulate Raf-1 and
A-Raf but not B-Raf, activity (Figure 6A). As expected,
expression of Gao-Q205L failed to affect activation of
cotransfected HA-p44 MAPK by FGF (Figure 6B).
Activation of B-Raf by Receptors Coupled to Go
To establish whether receptor-mediated activation of Gao
induces the B-Raf response observed after expression of the
constitutively active subunit, we transiently transfected into
CHO cells the dopaminergic D2 receptor, which couples to
both Gi and Go proteins (Liu et al., 1994; Watts et al., 1998).
Exposure of D2 receptor-expressing cells to dopamine for 5
and 20 min stimulated the activity of B-Raf by ;70 and 60%,
respectively (Figure 7A). This response was completely abol-
ished by pretreatment with 100 ng/ml PTX for 16 h (our
unpublished results). Because CHO cells express Go as well
as Gi2 and Gi3 (Dell’Acqua et al., 1993; van Biesen et al.,
1996a), dopamine activation of B-Raf could be mediated by
any of the subunits composing these heterotrimers. To de-
termine the role of Gao in the D2 receptor response, we first
investigated the ability of Gai2, Gai3, and Gbg to activate
B-Raf. As shown in Figure 7A, expression of either activated
Gai2 and Gai3 subunits or Gb1g2 complexes failed to signif-
icantly increase B-Raf activity. We then asked whether acti-
vation of B-Raf by D2 receptors is enhanced by cotransfec-
tion of wild-type Gao, which, by associating with
endogenous Gbg chains, is expected to form heterotrimers
available for receptor coupling. As shown in Figure 7B,
expression of wild-type Gao markedly increased dopamine-
induced stimulation of B-Raf activity. Consistent with an
effect mediated, at least in part, by Gao, B-Raf activation by
the D2 receptor was not affected by coexpression of N17-Ras
but was largely inhibited by PMA pretreatment and wort-
mannin (Figure 7C). We finally investigated whether stim-
ulation of the kinase activity of B-Raf by receptor-activated
Gao has a positive effect on the MAPK pathway. In CHO
cells, D2 receptors caused a marked stimulation of endoge-
nous p42 MAPK activity (Figure 8), which was totally
blocked by pretreatment with PTX (our unpublished re-
sults). However, p42 MAPK displayed a more transient
activation than B-Raf. The average 12-fold increase in p42
MAPK activity observed at 5 min was greatly reduced at 20
min (Figure 8). A complete dissociation between the effects
of the D2 receptor on B-Raf and MAPK became apparent in
cells cotransfected with N17-Ras or pretreated with PMA.
Coexpression of N17-Ras, which has no effect on B-Raf ac-
tivation, efficiently inhibited the stimulation of p42 MAPK
activity (Figure 8A). Conversely, PMA pretreatment, which
largely prevents activation of B-Raf, did not significantly
modify the p42 MAPK response (Figure 8B). These results
indicate that, upon stimulation of the D2 receptor, Gao-
activated B-Raf does not induce a MAPK response. Cumu-
latively, the data are consistent with the conclusion that
expression of mutationally activated Gao and receptor-de-
pendent activation of this subunit exert a similar effect on
the B-Raf kinase.
DISCUSSION
Expression of mutationally activated Ga chains or free Gbg
complexes in appropriate cell systems has greatly facilitated
Figure 6. Activated Gao does not affect MAPK stimulation by FGF
receptors. (A) Effect of FGF on Raf activity in nontransfected CHO
cells grown in 10-cm dishes. (B) Effect of Gao on FGF-stimulated
MAPK activity in CHO cells transfected in 6-cm dishes with 1.4 mg
of HA-p44 MAPK and 1.4 mg of empty vector, Gao-WT, or Gao-
Q205L. Cells were serum starved for 18 h before stimulation with 40
ng/ml FGF for 5 min. Raf-1, A-Raf, B-Raf, and HA-p44 MAPK
activities were determined as described in the legends to Figures 1
and 5. Data are means 6 SE for duplicate samples from two inde-
pendent experiments.
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the understanding of the roles of individual G protein sub-
units in the regulation of intracellular signaling pathways.
We have used this approach to investigate the effect of Gao
on the MAPK pathway. When expressed in CHO cells, ac-
tivated Gao is not sufficient to induce MAPK activation but
substantially augments the stimulatory response to the EGF
receptor. Previous studies have shown that other Ga chains
regulate the MAPK pathway in a similar manner. Expres-
sion of activated Ga12 or Ga13 significantly increases MAPK
activity when Rat-1 cells are exposed to EGF (Voyno-
Yasenetskaya et al., 1994). Activated Gaq, which in certain
cell types acts on its own (van Biesen et al., 1996b), requires
the concomitant activation of PDGF receptors to stimulate
MAPK activity in quiescent NIH 3T3 fibroblasts (De Vivo
and Iyengar, 1994). However, the molecules and mecha-
nisms involved in the interaction between these G protein
subunits and the tyrosine kinase receptor signaling pathway
have not been identified.
Receptors coupled to Gi/o proteins can stimulate the
MAPK pathway by inducing ligand-independent tyrosine
phosphorylation of the EGF receptor (Hackel et al., 1999;
Luttrell et al., 1999). The fact that the MAPK response to
activated Gao is clearly dependent on the presence of EGF
argues against an involvement of this mechanism. Consis-
tently, we found that expression of Gao-Q205L does not
cause tyrosine phosphorylation of the EGF receptor. The
finding that activated Gao markedly increases MAPK acti-
vation by Ras further supports the conclusion that this sub-
unit acts on a signaling molecule located downstream of the
EGF receptor. A low “basal” activity of transfected EGF
receptors therefore seems the most likely explanation of the
modest activation of MAPK induced by Gao-Q205L in the
absence of EGF.
We have identified the B-Raf kinase as a site for conver-
gence of the signaling pathways initiated by the EGF recep-
tor and Gao. There is increasing evidence for a differential
regulation of the Raf family members by cell surface recep-
tors (Reuter et al., 1995; Knall et al., 1996; Marais and Mar-
shall, 1996; van Biesen et al., 1996b; York et al., 1998). Acti-
vation of the Raf kinases by growth factors varies among
individual tyrosine kinase receptors and individual cell
types (Reuter et al., 1995; Marais and Marshall, 1996). We
found that in CHO cells the EGF receptor induces activation
of B-Raf without significantly affecting Raf-1 and A-Raf ac-
tivities. The results of several studies have shown that EGF
activates Raf-1 in various cell types, but not in Swiss 3T3
fibroblasts, and stimulates B-Raf activity in PC12 cells (Ma-
rais and Marshall, 1996). Regulation of the Raf kinase family
by receptors coupled to Gi/o proteins is less understood.
Most work has concentrated on Raf-1 (van Biesen et al.,
1996b), but there is evidence that Gi/o-coupled receptors also
activate B-Raf (Knall et al., 1996). However, whether the
subunits composing the Gi/o heterotrimers differ in their
ability to regulate specific Raf kinases has not been estab-
lished. Here we show that activated Gao selectively stimu-
lates the activity of B-Raf in CHO cells. Interestingly, our
experiments did not detect any significant effect of either Gai
or Gbg subunits on this kinase.
The lack of correlation between B-Raf and MAPK activi-
ties observed in cells expressing activated Gao clearly indi-
cates that the effect of this subunit on B-Raf is sufficient to
promote MEK and MAPK activation in in vitro assays but
not in intact cells. Such a discrepancy cannot be explained by
the fact that we used MEK1, rather than MEK2, to measure
B-Raf activity. The two MEK kinases appear equally respon-
sive to B-Raf activation (Marais et al., 1997) and are ex-
Figure 7. B-Raf activation by dopaminergic D2 receptors. CHO cells transfected in 6-cm dishes were serum starved for 18 h and either left
untreated or stimulated with 100 nM dopamine (DA) for 5 or 20 min. B-Raf activity was assayed as described in the legend to Figure 5. Data
shown represent means 6 SE of two independent experiments performed in duplicate. (A) Cells were transfected with 1.8 mg of
dopaminergic D2 receptor (D2R), 1.8 mg of wild-type or activated Gai2 and Gai3 subunits, or 1.4 mg of Gb1 and Gg2 chains. *, Significantly
higher than basal (p , 0.05 by unpaired t test). (B) Cells were transfected with 1.8 mg of D2R and, where indicated, 1.8 mg of Gao-WT. *,
Significantly higher than values obtained in the absence of Gao-WT (p , 0.01 by unpaired t test). (C) Cells were transfected with 1.4 mg of
D2R and, where indicated, 2.8 mg of N17-Ras. PMA pretreatment and incubation with wortmannin were as described in the legend to Figure
5. Results are expressed as percentages of the increase induced by DA in control cells.
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pressed in comparable amounts in CHO cells (Pace et al.,
1995; Xu et al., 1997) (our unpublished results). In addition,
the data obtained with the dopaminergic D2 receptor seem
to rule out the possibility that the “defective” response of
B-Raf to Gao is dependent on compensatory mechanisms or
irrelevant effects that result from expression of the mutation-
ally activated protein. It should also be considered that CHO
cells contain at least two of the multiple B-Raf isoforms that
have been identified (Barnier et al., 1995). The antibodies
used in our experiments immunoprecipitate preferentially
the 92-kDa form (Vaillancourt et al., 1994), and the results of
kinase assays reflect mainly the activity of this protein. A
differential activation of the B-Raf kinases has been sug-
gested (Vossler et al., 1997), and it is therefore possible that
only the 92-kDa form is sensitive to the regulation observed
in our studies. However, because in cell lysates the 92-kDa
form is only slightly less abundant than the 66-kDa form
(our unpublished results), it appears unlikely that the levels
of expression of the protein can limit its ability to stimulate
MAPK in intact cells. Several lines of evidence suggest,
however, that B-Raf regulation is involved in the ability of
activated Gao to potentiate EGF receptor-dependent MAPK
activation: 1) the enhancement of Ras-stimulated MAPK
activity by Gao-Q205L is consistent with the involvement of
a signaling molecule located downstream of Ras itself; 2)
PKC inactivation and PI3K inhibition, which abolish B-Raf
activation by Gao-Q205L, completely prevent the effect of
the mutant subunit on MAPK; and 3) activated Gao has no
significant effect on the MAPK response induced by FGF,
which does not activate the B-Raf kinase in CHO cells.
Although we cannot exclude other possibilities, the simplest
interpretation of our results is that Gao-activated B-Raf can
efficiently stimulate the downstream MAPK cascade in the
presence of a concomitant signal provided by the EGF re-
ceptor (see Figure 9).
Activation of B-Raf and the other members of the Raf
family is a complex process involving mechanisms that have
not been completely elucidated (Marais and Marshall, 1996;
Morrison and Cutler, 1997; Campbell et al., 1998). The ability
of Ras to activate B-Raf is well established. The binding of
Ras induces translocation of B-Raf to the plasma membrane
and potently stimulates its kinase activity (Marais et al.,
1997). Recently, it has been reported that B-Raf is also di-
rectly activated by the small G proteins Rap1 and TC21
(Vossler et al., 1997; York et al., 1998; Rosario et al., 1999). The
results obtained here in cells expressing Gao-Q205L or the
dopaminergic D2 receptor indicate that Gao regulates B-Raf
activity by a Ras-independent mechanism that involves both
PKC and PI3K. Previous studies have reported that PKC and
PI3K can lead to B-Raf activation (Peraldi et al., 1995; Reuter
et al., 1995; Knall et al., 1996). The Ras-independent pathway
connecting these signaling molecules to B-Raf remains to be
defined. On the other hand, the fact that activated Gao
potentiates the action of Ras on the MAPK pathway would
suggest that Ras activation is the EGF receptor-dependent
signal that cooperates with the G protein subunit in regu-
lating B-Raf function. We do not know how Gao increases
the kinase activity of B-Raf without allowing coupling of the
kinase to its downstream effectors and how the tyrosine
kinase receptor-Ras dependent pathway would promote the
latter event. Mechanisms that influence the ability of B-Raf
to activate MEK might involve subcellular localization, as-
sociation with scaffolding proteins (Garrington and Johnson,
1999), or regulation by signaling molecules. Interestingly,
signals that control the coupling of Raf-1 to the MAPK
cascade have been recently reported. In NIH 3T3 cells ex-
posed to serum, “adhesion deprivation” has no major effect
on the in vitro activity of Raf-1 but strongly inhibits MAPK
stimulation (Renshaw et al., 1997). Similar results have been
obtained in HEK-293 cells stimulated with agonists of G
protein-coupled receptors after blockade of receptor inter-
Figure 8. Effects of N17-Ras expression and PMA pretreatment on
dopamine-stimulated MAPK activity. CHO cells transfected in 6-cm
dishes were serum starved for 18 h and stimulated with 100 nM DA
for 5 or 20 min. (A) Cells were transfected with 1.4 mg of D2R and 2.8
mg of either empty vector or N17-Ras. (B) Cells were transfected
with 1.4 mg of D2R and pretreated with PMA as described in the
legend to Figure 5. Endogenous p42 MAPK activity was measured
as described in the legend to Figure 1. Data are means 6 SE of
triplicate determinations. Similar results were obtained in at least
one additional experiment.
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nalization (Daaka et al., 1998). Finally, it should be men-
tioned that during the preparation of this manuscript two
reports have shown that both Gai and Gao can interact with
Rap1GAP (Jordan et al., 1999; Mochizuki et al., 1999). It has
been proposed that Rap1GAP binds more avidly to the
inactive form of Gao, and activation of the G protein subunit
leads to the release of the GTPase-activating protein and the
consequent inhibition of Rap1 function (Jordan et al., 1999).
In cells in which Rap1 exerts a positive effect on B-Raf and
MAPK, such as the PC12 line, this mechanism causes in-
creased MAPK activity in response to wild-type but not
constitutively activated Gao (Jordan et al., 1999). Because
other recent data suggest that Rap-1 induces B-Raf and
MAPK activation also in CHO cells (Seidel et al., 1999), it is
difficult to imagine how inhibition of this small G protein
can explain our present results. However, the effects of Rap1
on the MAPK pathway are rather complex and not com-
pletely understood (Bos and Zwartkruis, 1999), and further
work will be needed to elucidate the role of Rap1GAP
regulation in B-Raf and MAPK stimulation by Gao.
Different Ga chains have a well-recognized role in the
control of cell growth (Landis et al., 1989; Vallar, 1996; Dha-
nasekaran et al., 1998). The finding that Gao can exert a
positive effect on MAPK activity reinforces the idea that this
subunit is involved in mitogenic signaling pathways (Kroll
et al., 1991; Kroll et al., 1992; van Biesen et al., 1996a). Our
results can explain the increased proliferative response to
serum previously observed in NIH 3T3 fibroblasts express-
ing Gao-Q205L (Kroll et al., 1992), especially when taking
into account that in these cells B-Raf has been identified as
one of the major MEK activators (Reuter et al., 1995). It
appears conceivable that the effect of activated Gao identi-
fied here also represents one of the mechanisms responsible
for the synergistic effects of Gi/o-coupled receptors and ty-
rosine kinase receptors on MAPK and cell growth observed
in several systems (Meloche et al., 1992b; Pouyssegur and
Seuwen, 1992; Vouret-Craviari et al., 1993; Fujitani and Ber-
trand, 1997). Interestingly, a synergistic stimulation of
MAPK activity by dopaminergic D2 receptors and EGF re-
ceptors can be detected in CHO cells (our unpublished
results). Our experiments indicate that activated Gao re-
quires the concomitant stimulation of the EGF receptor-Ras
signaling pathway to regulate MAPK activity. However,
previous results obtained in CHO cells expressing a PTX-
insensitive mutant of Gao have proposed that this subunit
mediates Ras-independent and PKC-dependent MAPK acti-
vation by the muscarinic M1 receptor (van Biesen et al.,
1996a). We cannot exclude the possibility that, in our exper-
iments, desensitization or counter-regulation mechanisms
prevent the detection of autonomous effects of Gao on the
MAPK pathway. However, it is also possible that upon
activation of the muscarinic M1 receptor, which couples to
both Go and Gq, other G protein subunits provide a Ras-
independent signal that allows stimulation of the MAPK
cascade by Gao-activated B-Raf. The existence of such
“cross-talk” mechanisms would be one of the possible ex-
planations of the fact that in CHO cells certain receptors
capable of coupling to the Go protein use a PKC-dependent
pathway of MAPK activation (van Biesen et al., 1996a; Wylie
et al., 1999), but others, like the dopaminergic D2 receptor
investigated here, are clearly unable to do so (Garnovskaya
et al., 1996; Hawes et al., 1998) (see Figure 9). The ability of G
protein subunits to regulate the MAPK pathway by a variety
of signals (van Biesen et al., 1996b; Gutkind, 1998), including
transactivation of tyrosine kinase receptors (Hackel et al.,
1999; Luttrell et al., 1999), suggests that there are several
ways by which Gao-activated B-Raf might participate in the
MAPK responses induced by G protein-coupled receptors in
specific cell types.
The effector molecules and intracellular pathways in-
volved in signal transduction mechanisms by Gao are poorly
understood. There is evidence that Gao can directly inhibit a
specific adenylyl cyclase isoform, which is mainly expressed
in brain (Sunahara et al., 1996). Other reported effects of the
active form of Gao include stimulation of polyphosphoino-
sitide hydrolysis and PKC activity in Xenopus oocytes (Mo-
riarty et al., 1990; Kroll et al., 1991) and activation of a Src-like
kinase pathway in neurons (Diverse´-Pierluissi et al., 1997).
Our results indicate that in CHO cells signaling from Gao
involves PKC, as previously suggested (van Biesen et al.,
1996a), as well as PI3K. The identities of the PKC and PI3K
isoforms that participate in Gao-mediated signals and their
mechanisms of regulation remain to be clarified. In CHO
cells, Gao uses PKC and PI3K to induce Ras-independent
activation of B-Raf and conditional stimulation of MAPK. It
appears most likely that these responses occur in a set of
Figure 9. Model of signaling pathways regulating
Raf and MAPK in CHO cells. The EGF receptor (EGFR)
activates Ras and B-Raf, whereas the FGF receptor
(FGFR) activates Ras, Raf-1, and A-Raf. Activated Gao
potentiates MAPK activation by Ras and EGFR but not
FGFR. The G protein subunit stimulates the kinase
activity of B-Raf by a Ras-independent and PKC- and
PI3K-dependent mechanism, which is insufficient to
promote MAPK activation. It is proposed that this
mechanism can efficiently stimulate the MAPK path-
way in the presence of a B-Raf-activating signal from
Ras or the EGFR. The dopaminergic D2 receptor (D2R),
which couples to both Gi and Go, appears to stimulate
MAPK through Ras activation of Raf-1. This effect is
presumably mediated by G protein bg complexes and,
possibly, Gai subunits. Upon stimulation of this recep-
tor, the Ras-independent and PKC- and PI3K-depen-
dent activation of B-Raf induced by Gao does not pro-
duce a MAPK response.
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selected cell types (van Biesen et al., 1996a,b; Gutkind, 1998).
Gao is believed to play a most important role in the nervous
system (Neer, 1995; Jiang et al., 1998), where B-Raf is ex-
pressed at particularly high levels (Barnier et al., 1995). Re-
cent data have shown that, in PC12 cells overexpressing
Rap1, constitutively active Gao has a negative rather than a
positive effect on the MAPK response to NGF (Jordan et al.,
1999). It will be of considerable interest to elucidate whether
the signaling pathway identified here in CHO cells operates
in other neuronal models and is therefore involved in intra-
cellular networks that regulate not only growth but also
differentiation and specialized cell functions.
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